Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Drug Delivery Devices Market, By Route of Administration
7.1. Drug Delivery Devices Market, By Route of Administration Type, 2020-2027
7.1.1. Oral
7.1.1.1. Market Revenue and Forecast (2016-2027)
7.1.2. Inhalation
7.1.2.1. Market Revenue and Forecast (2016-2027)
7.1.3. Transdermal
7.1.3.1. Market Revenue and Forecast (2016-2027)
7.1.4. Injectable
7.1.4.1. Market Revenue and Forecast (2016-2027)
7.1.5. Ocular
7.1.5.1. Market Revenue and Forecast (2016-2027) )
7.1.6. Nasal
7.1.6.1. Market Revenue and Forecast (2016-2027) )
7.1.7. Topical
7.1.7.1. Market Revenue and Forecast (2016-2027)
7.1.8. Others
7.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 8. Global Drug Delivery Devices Market, By Vehicles
8.1. Drug Delivery Devices Market, By Vehicles, 2020-2027
8.1.1. Oncology
8.1.1.1. Market Revenue and Forecast (2016-2027)
8.1.2. Infectious Diseases
8.1.2.1. Market Revenue and Forecast (2016-2027)
8.1.3. Respiratory Diseases
8.1.3.1. Market Revenue and Forecast (2016-2027)
8.1.4. Diabetes
8.1.4.1. Market Revenue and Forecast (2016-2027)
8.1.5. Cardiovascular Diseases
8.1.5.1. Market Revenue and Forecast (2016-2027)
8.1.6. Autoimmune Diseases
8.1.6.1. Market Revenue and Forecast (2016-2027)
8.1.7. Central Nervous System Disorders
8.1.7.1. Market Revenue and Forecast (2016-2027)
8.1.8. Others
8.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 9. Global Drug Delivery Devices Market, By Vehicles
9.1. Drug Delivery Devices Market, By Vehicles, 2020-2027
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2016-2027)
9.1.2. Diagnostic Centers
9.1.2.1. Market Revenue and Forecast (2016-2027)
9.1.3. Ambulatory Surgery Centers/Clinics
9.1.3.1. Market Revenue and Forecast (2016-2027)
9.1.4. Home Care Settings
9.1.4.1. Market Revenue and Forecast (2016-2027)
9.1.5. Other
9.1.5.1. Market Revenue and Forecast (2016-2027)
Chapter 10. Global Drug Delivery Devices Market, By Vehicles
10.1. Drug Delivery Devices Market, By Vehicles, 2020-2027
10.1.1. Hydrogel
10.1.1.1. Market Revenue and Forecast (2016-2027)
10.1.2. Micelle
10.1.2.1. Market Revenue and Forecast (2016-2027)
10.1.3. Dendrimer
10.1.3.1. Market Revenue and Forecast (2016-2027)
10.1.4. Nanoparticle
10.1.4.1. Market Revenue and Forecast (2016-2027)
10.1.5. Liposome
10.1.5.1. Market Revenue and Forecast (2016-2027)
10.1.6. Scaffold
10.1.6.1. Market Revenue and Forecast (2016-2027)
10.1.7. Mesoporous Material
10.1.7.1. Market Revenue and Forecast (2016-2027)
10.1.8. Niosomes
10.1.8.1. Market Revenue and Forecast (2016-2027)
Chapter 11. Global Drug Delivery Devices Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.1.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.1.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.1.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.1.5. U.S.
11.1.5.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.1.5.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.1.5.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.1.5.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.1.6. Rest of North America
11.1.6.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.1.6.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.1.6.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.1.6.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2. Europe
11.2.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.2.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.5. UK
11.2.5.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.2.5.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.5.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.5.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.6. Germany
11.2.6.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.2.6.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.6.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.6.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.7. France
11.2.7.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.2.7.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.7.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.7.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.8. Rest of Europe
11.2.8.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.2.8.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.8.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.2.8.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3. APAC
11.3.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.3.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.5. India
11.3.5.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.3.5.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.5.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.5.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.6. China
11.3.6.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.3.6.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.6.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.6.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.7. Japan
11.3.7.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.3.7.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.7.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.7.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.8. Rest of APAC
11.3.8.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.3.8.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.8.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.3.8.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4. MEA
11.4.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.4.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.5. GCC
11.4.5.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.4.5.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.5.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.5.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.6. North Africa
11.4.6.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.4.6.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.6.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.6.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.7. South Africa
11.4.7.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.4.7.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.7.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.7.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.8. Rest of MEA
11.4.8.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.4.8.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.8.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.4.8.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.5. Latin America
11.5.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.5.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.5.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.5.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.5.5. Brazil
11.5.5.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.5.5.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.5.5.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.5.5.4. Market Revenue and Forecast, By Vehicles (2016-2027)
11.5.6. Rest of LATAM
11.5.6.1. Market Revenue and Forecast, By Route of Administration (2016-2027)
11.5.6.2. Market Revenue and Forecast, By Vehicles (2016-2027)
11.5.6.3. Market Revenue and Forecast, By Vehicles (2016-2027)
11.5.6.4. Market Revenue and Forecast, By Vehicles (2016-2027)
Chapter 12. Company Profiles
12.1. Pfizer, Inc
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Johnson & Johnson Services, Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. F. Hoffmann-La Roche, Ltd
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Novartis AG; BD
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Bayer AG.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. uniQure N.V
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Sibiono GeneTech Co. Ltd.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
Glossary of Terms